Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Summary

This is a single arm pilot trial to evaluate the feasibility of using a simvastatin intervention, and to evaluate its effects on cancer progression, among 20 patients with platinum-sensitive ovarian cancer, treated with carboplatin and liposomal doxorubicin at Cedars-Sinai Medical Center.

Timeline

Start

2021-01-25

Primary completion

2024-11-01

Completion

2025-05-12

Drugs

Indications